Complete Conference Management 26th Annual San Diego Heart Failure Winter Symposium 2026

Description

+ Include: 53 videos + 53 file sub vtt + 40 pdfs, size: 17.36 GB
+ Target Audience: cardiologists, internists, primary care physicians, family medicine physicians
+ Sample video: contact me for sample video
+ Information:
26th Annual San Diego Heart Failure Winter Symposium: New Strategies for Detection, Prevention and Treatment of Heart Failure is organized by Complete Conference Management (CCM) and will be held from Jan 23 – 24, 2026 at Hilton La Jolla Torrey Pines, La Jolla, California, United States of America.
This year’s 26th Annual San Diego Heart Failure Winter Symposium – New Strategies for Detection, Prevention and Treatment of Heart Failure on January 23 & 24, 2026 aims to provide a comprehensive overview of how to best manage patients with heart failure at all stages of disease. This accredited program emphasizes practical aspects of heart failure management beginning with prevention of clinically manifest disease in patients at risk and extending to end-stage heart failure. Over the course of two days, the focused sessions that include lectures, case discussions and moderated panels will provide expert insight and personal experience that cover the full range of management options that are available for managing patients throughout the spectrum of heart failure. The agenda of the Winter 2026 Symposium includes content that extends from recognition of patients with cardiovascular-renal-metabolic syndrome (CRMS) who are risk of developing heart failure to the management of patients with symptomatic heart failure including those with cardiogenic shock or end-stage disease. Advances in drug and device therapy will receive extensive coverage throughout the Symposium. Insights into the recognition and management of less common (but not less important) causes of disease including genetic mutations are important areas that will be reviewed. Throughout the Symposium, best practices and emerging strategies for diagnosis and treatment are emphasized. By combining case vignettes, patient narratives, didactic lectures and insightful panel discussions, attendees will have the opportunity to gain state of the art insights into the management of patients with heart failure. Our goal, as always, is to provide cutting edge information in a format that will enhance adaption of the knowledge that is gained into clinical practice..
SYMPOSIUM OBJECTIVES:

Summarize current and emerging treatments available for preventing and treating heart failure and provide information to help in the selection of the most effective choices in individual patients.
Review strategies for implementing medical and device therapies that will lead to improved outcomes in heart failure patients.
Define how specific populations including minorities, women and the elderly respond to various approaches to treating risk factors and heart failure.

TARGET AUDIENCE
This course is designed for cardiologists, internists, primary care physicians, nurses, PA’s, PharmD’s and all other allied healthcare professionals with an interest in heart failure.

+ Topics:

01 Recognizing the Cardio-Renal-Metabolic Syndrome (CRMS) and It’s Importance in Practice

02 Role of SGLT2 Inhibitors in Treating Patients with DCRM Conditions

03 Emerging Evidence that GLP-1 Agonists Can Prevent CV Disease in Patients with CRMS

04 Advances in the Management of Patients with Dyslipidemia

05 Use of Finerenone To Prevent CV Disease, CKD and Heart Failure

06 Moderated Panel

07 Percutaneous Valve Replacement and Repair

08 Advances in the Management of Pulmonary Arterial Hypertension

09 Recognizing and Treating Patients with Amyloidosis

10 Advances in the Management of Patients with Hypertrophic Cardiomyopathy

11 Managing Patients with Cardiac Sarcoidosis and Other Infiltrative Diseases

12 Moderated Panel Discussion

13 Introduction to Rare Diseases and Gene Therapy

14 Gene Therapy from Bench to Bedside

15 Genetic Testing – Who, What, When and Why

16 Genetic Counseling

17 Gene Therapy for Genetic Cardiomyopathies

18 Gene Therapy for Lysosomal Storage Diseases

19 Genetic Diseases from the Patient Perspective

20 Moderated Panel Discussion – Session 4

21 Advances in the Management of Patients with Symptomatic HFrEF

22 Emerging Approaches for Managing Patients with Symptomatic HFpEF

23 Monitoring Devices To Identify and Treat Congestion

24 What’s New in 2026

25 Moderated Panel Discussion – Session 5

26 Recognizing Preshock-The Early Warning Signs

27 Diagnosis and Initial Management of Cardiogenic Shock

28 Mechanical Circulatory Support in Escalating Shock

29 Surgical Intervention for Advanced Cardiogenic Shock

30 Moderated Panel Discussion – Session 6

31 Emerging Approaches for Categorizing and Treating Patients with Myocarditis and Chronic Pericarditis

32 Approaches for Managing Patients with Atrial Fibrillation and Preventing Thromboembolism

33 Chemotherapy Induced Cardiomyopathy- Prevalence, Risk and Prevention

34 Identifying Patients at Risk of Sudden Cardiac Death

35 Who Is A Candidate for Advanced Therapies

36 Outcomes From Cardiac Transplantation and LVAD

37 Moderated Panel Discussion – Session 8

38 Case Vignettes Cardiogenic shock in pregnancy

39 Clinical Vignettes Wettersten_Case

40 Case Vignettes Dixit_Case

41 Case Vignettes Shen_Case

42 Case Vignettes Taub_Cases

43 Case Vignettes

Case Vignettes Day 1

Clinical Vignettes Day 2

Session I-Defining and Managing the Cardio-Renal-Metabolic Syndrome

Session II- Cardio-Oncology and Pulmonary Arterial Hypertension

Session III- Amyloid and Other Infiltrative Heart Disease, Hypertrophic Cardiomyopathy and HFpEF

Session IV- Rare Diseases and Gene Therapy

Session V- Managing Patients with Stage C Heart Failure

Session VI- Shock and Pre-Shock- Diagnosis and Management

Session VII- Myocarditis, Pericarditis, Arrhythmias, Treating Valvular Heart Disease and Preventing Sudden Cardiac…

Session VIII- Advanced Therapies for Heart Failure